EPISODE · Feb 6, 2020 · 37 MIN
Show 96 - PharmaComms - Part 1
from the c-suite podcast · host the c-suite podcast
The first of two episodes recorded in partnership with PRWeek UK at their PharmaComms conference in London where we chatted with a number of speakers from the event. 1/ Rachel Royall, Communications Director UK Healthcare & Life Sciences, IBM - 'What does patient-centricity mean for communications?' 2/ Christian Marcoux, Senior Vice President, Global Communications, Ipsen - 'Corporate Relevance - why relevance is the new reputation' 3/ Avril Fudge, Communications and PR Lead EMENA, Accord Healthcare - 'Informing and equipping employees to become brand ambassadors' 4/ David Flynn, Head Of External Communications, Roche; Charlotte Davies, Head of Communications, Healthcare, Merck; Kristine Kelly, Head of Communications and Patient Advocacy, UK, Novartis - 'Innovation and regulation: how to master the balancing act of communications in Pharma'
What this episode covers
The first of two episodes recorded in partnership with PRWeek UK at their PharmaComms conference in London where we chatted with a number of speakers from the event. 1/ Rachel Royall, Communications Director UK Healthcare & Life Sciences, IBM - 'What does patient-centricity mean for communications?' 2/ Christian Marcoux, Senior Vice President, Global Communications, Ipsen - 'Corporate Relevance - why relevance is the new reputation' 3/ Avril Fudge, Communications and PR Lead EMENA, Accord Healthcare - 'Informing and equipping employees to become brand ambassadors' 4/ David Flynn, Head Of External Communications, Roche; Charlotte Davies, Head of Communications, Healthcare, Merck; Kristine Kelly, Head of Communications and Patient Advocacy, UK, Novartis - 'Innovation and regulation: how to master the balancing act of communications in Pharma'
NOW PLAYING
Show 96 - PharmaComms - Part 1
No transcript for this episode yet
Similar Episodes
Apr 26, 2026 ·35m
Apr 25, 2026 ·141m
Apr 24, 2026 ·55m
Apr 23, 2026 ·54m
Apr 22, 2026 ·40m
Apr 21, 2026 ·64m